19.6 C
New York
Tuesday, August 16, 2022

Biomerica, Inc. (BMRA) stock is soaring today: Why is it so?

Shares of the Biomerica, Inc. (BMRA) stock were soaring today following the announcement of its agreement with Walmart. BMRA stock price saw a surge of 34.22% to reach $6.00 a share at the time of this writing. The stock was gloomy in the previous trade and went down by 3.43% at closing. Let’s discuss BMRA stock in-depth and understand its recent events.

Biomerica, Inc is the medical stock that operates by developing, manufacturing, and marketing of therapeutics to treat medical conditions across the globe. The company is manufacturing diagnostics kits that analyze blood, urine, and fecal specimens to diagnose medical complications in patients.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


What’s Happening?

Biomerica recently announced that it has signed the General Merchandise Supplier Agreement with Walmart. According to the agreement, Biomerica stock will sell its EZ Detect™ colorectal disease screening test through the Walmart retail system. The first orders of the EZ Detect™ product have now been shipped to Walmart. Walmart has initiated the sale of products via its online sales channel since the beginning of this week.

BMRA stock is in the final stages of working with Walmart to sell and stock the EZ Detect product on the shelf in their stores. Moreover, the company is negotiating with many large other companies to distribute the EZ Detect™ product in Asia, Europe, and the Middle East.

Previous Announcement by BMRA stock:

On August 30, 2021, BMRA stock announced the expectation of final patient enrollment for its endpoint clinical trial of InFoods® diagnostic-guided therapy (DGT). The DGT is meant to decrease irritable bowel syndrome (IBS) symptoms. BMRA stock expects the end of treatment of patients in the endpoint clinical trial by the end of October 2021. After the treatment, the trial team will save the data and perform statistical analysis. The stock expects to release efficacy results InFoods® IBS product by the end of this year.

BMRA stock launched the new Website for EZ Detect™ Colorectal Disease Screening Test:

Biomerica stock did announce the launch of its new website for its EZ Detect™ Colon Disease Test product at https://ezdetect.com. The information regarding treatment and detection of colorectal diseases including colon cancer is easily accessible. The stock is also promoting the EZ Detect™ product via digital health advertising and social media campaigns through its newly created website.

Conclusion:

The Covid-19 has developed the habit of home diagnostic testing in consumers as they feel safer in performing these tests. Now many retailers around the globe are selling home health solutions and this growing trend has opened the door of opportunities for the Biomerica stock.

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here

2887

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

DOWNLOAD FREE EBOOK

BEST INFLATION STOCKS 2022

We put together a list of the best stocks that

we think can explode over the next 12 months.

2888

SPECIAL GIFT

2889
2890
2891

  What you will Get ?

   Best Inflation

   Stocks eBook

        Hot Stocks Alert

     before the opening

                  bell

        Special Offer

      and reports from 

        our partners

100% free. stop anytime no spam

GET YOUR FREE COPY NOW

DOWNLOAD FREE EBOOK

BEST GROWTH STOCKS 2022

We put together a list of the best stocks that we

think can explode over the next 12 months.

2899

SPECIAL GIFT

2900
2901
2902

  What you will Get ?

   Best Growth

   Stocks eBook

        Hot Stocks Alert

     before the opening

                  bell

        Special Offer

      and reports from 

        our partners

2903

100% free. stop anytime no spam

GET YOUR FREE COPY NOW

2915

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

2839

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam